(ADDV-A) ADDvise - Ratings and Ratios

Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0001306119

ADDV-A: Lab Equipment, Medical Devices, Pharmaceuticals, Software, Cleanrooms

ADDvise Group AB (publ) is a leading supplier of specialized equipment and solutions to healthcare and research sectors globally, operating across Europe, North America, South America, Asia, and other international markets. The companys operations are divided into two core business units: Lab and Healthcare.

The Lab business unit specializes in providing advanced laboratory infrastructure and equipment, including laboratory furnishings, ventilation systems, climate-controlled environments, and cleanrooms. These solutions are tailored for pharmaceutical companies, biotechnology firms, and research institutions, supporting their operational and scientific needs.

The Healthcare business unit focuses on medical equipment, pharmaceuticals, and consumables, catering to specialties such as urology, gynecology, emergency care, and surgery. The unit also manufactures surgical tables and offers a range of cables, connectors, and wires. Additionally, it provides customized solutions for the rental and sale of medical and laboratory equipment for clinical studies.

Further, the company designs and delivers customized cleanrooms, climate-controlled rooms, and laboratory furniture. It distributes medical devices, including continuous glucose monitors and insulin pumps, as well as orthopedic solutions like implants and surgical instruments. The company also develops software and instruments for quantifying patient mobility, pain levels, and muscle strength.

Other offerings include healthcare and industrial ultrasound devices for medical and non-destructive testing (NDT) applications. The company operates a mail-order pharmacy and develops, manufactures, and markets over-the-counter (OTC) generic drugs for pain management, respiratory conditions, and urological treatments. It also provides products and software for monitoring vital signs in long-term care settings and markets colorimetric CO2 indicators used in respiratory and emergency care.

Originally founded as ADDvise Lab Solutions AB (publ) in 1989, the company rebranded to ADDvise Group AB (publ) to reflect its expanded scope. Headquartered in Stockholm, Sweden, it has established itself as a diversified provider of critical solutions for healthcare and life sciences industries.

Ticker Symbol: ADDV-A Exchange: ST Type: common stock Country Origin: Sweden GICS Sub Industry: Life Sciences Tools & Services Average Volume 20d: 5588 Last Price: 8.42 SMA 20: 6.56 SMA 50: 7.65 SMA 200: 12.37 ATR: 0.35 Market Cap: 318.54M SEK P/E: 10.21 P/E Forward: 8.46 P/B: 1.51 P/S: 0.20 RoE: 10.78 3-Month Forecast: Based on the provided data, ADDV-A is expected to experience a mixed outlook. The stock is currently trading below its SMA 200 (12.37), indicating potential bearish momentum. However, the forward P/E of 8.46 suggests undervaluation, which could attract investors. With an ATR of 0.35, volatility is moderate. Overall, the stock may face short-term headwinds but could stabilize as fundamentals improve.

Additional Sources for ADDV-A Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

ADDV-A Stock Overview

Market Cap in USD 48m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC Sub-Industry Life Sciences Tools & Services
IPO / Inception

ADDV-A Stock Ratings

Growth 5y 49.6%
Fundamental 46.8%
Dividend 1.0%
Rel. Strength Industry -39.2
Analysts -
Fair Price Momentum 7.91 SEK
Fair Price DCF 19.65 SEK

ADDV-A Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y -100.00%
Payout Consistency 1.0%

ADDV-A Growth Ratios

Growth Correlation 3m -50.4%
Growth Correlation 12m -65.7%
Growth Correlation 5y 78.8%
CAGR 5y 50.27%
CAGR/Max DD 5y 0.63
Sharpe Ratio 12m -0.07
Alpha -43.79
Beta -0.23
Volatility 182.82%
Current Volume 2.3k
Average Volume 20d 2.5k
What is the price of ADDV-A stocks?
As of March 13, 2025, the stock is trading at SEK 7.84 with a total of 2,301 shares traded.
Over the past week, the price has changed by -14.22%, over one month by +32.88%, over three months by -27.41% and over the past year by -39.22%.
Is ADDvise a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, ADDvise (ST:ADDV-A) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 46.83 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ADDV-A as of March 2025 is 7.91. This means that ADDV-A is currently overvalued and has a potential downside of 0.89%.
Is ADDV-A a buy, sell or hold?
ADDvise has no consensus analysts rating.
What are the forecast for ADDV-A stock price target?
According to ValueRays Forecast Model, ADDV-A ADDvise will be worth about 9.2 in March 2026. The stock is currently trading at 7.84. This means that the stock has a potential upside of +16.96%.
Issuer Forecast Upside
Wallstreet Target Price 13 65.8%
Analysts Target Price - -
ValueRay Target Price 9.2 17%